Law360, New York (July 19, 2012, 6:54 PM ET) -- A Minnesota federal judge on Thursday tossed a suit from a former employee accusing Bayer AG of misrepresenting the risks of its cholesterol drug Baycol — which was pulled after 31 deaths were linked to its use — and causing false claims to be submitted to Medicare.
U.S. District Judge Michael J. Davis dismissed with prejudice a second amended complaint by Laurie Simpson, a former Bayer senior market research analyst, finding that her False Claims Act allegations were not specific enough about which claims made to...
Bayer Beats Baycol FCA Suit
To view the full article, take a free trial now.
